Adicet Bio, Inc. ACET
Set alert
3.20 USD -0.22 -6.43%
At close
3.20 0.00 0.00%
Pre-market · Nov 3, 4:55 AM ET
3.18 Day range 3.47
3.18 52-week range 12.32
- YTD
- -62.00%
- 1 year
- -73.33%
- Open
- 3.42
- Prev close
- 3.42
- Mkt cap
- 29.96M
- Vol
- 250.31K
- Avg vol
- 198.78K
- EPS
- -10.42
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.18
- High
- 3.47
- Forward P/E
- -0.69
- Beta
- 1.70
- Short ratio
- 7.04
- Inst. own
- 76.44%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.16
- 200-d avg
- 1.48
- 1y target
- 6.40
Analyst view
Consensus: buy
Buy
Price target (mean) 6.40 +100.0% upside
Now 3.20
- Target (low)
- 4.00
- Target (mean)
- 6.40
- Target (high)
- 8.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy0
- Buy5
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.355 | -0.37 – -0.35 | -0.69 | +48.5% | 0 | 0.0% | 4 |
| Next quarter | -0.365 | -0.37 – -0.36 | -0.35 | -4.3% | 0 | 0.0% | 2 |
| Current year | -1.34 | -1.39 – -1.23 | -3.31 | +59.4% | 0 | 0.0% | 6 |
| Next year | -1.30 | -1.56 – -0.91 | -1.34 | +2.9% | 2.50M | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | HC Wainwright & Co. | Reiterated | Neutral | Neutral |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 24, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 23, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Apr 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 20, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 20, 2024 | Canaccord Genuity | Reiterated | Buy | Buy |
| Feb 2, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 5, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Nov 9, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Sep 6, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 10, 2023 | BTIG | Maintained | Buy | Buy |
| Aug 10, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Jun 27, 2023 | Guggenheim | Downgrade | Buy | Neutral |
| Jun 27, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 27, 2023 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Jun 1, 2023 | JP Morgan | Downgrade | Overweight | Neutral |
| May 15, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 10, 2023 | Wedbush | Reiterated | — | Outperform |
| May 10, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 16, 2023 | Wedbush | Reiterated | — | Outperform |
| Mar 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Dec 12, 2022 | HC Wainwright & Co. | Maintained | — | Buy |